Medical Equipment Management System for FY2026 Investment
Open tenderJapanese title: 【令和8年度医療機器投資】医療機器管理システム 一式
Overview
This procurement is for a complete medical equipment management system as part of the FY2026 medical equipment investment by the National Cancer Center. Delivery and implementation are required by March 31, 2027, at the National Cancer Center Central Hospital. The contract will be awarded by lowest price bid method with detailed specifications provided in the bidding documents.
Key Details
- Source: KKJ
- Notice type: Open tender
- Publication date: September 7, 2026
- Procuring entity: Manno Hiroyuki, Director of the National Cancer Center
- Deadline to obtain tender documents: September 30, 2026
- Submission deadline: September 30, 2026, 17:00 JST
- Award method: Lowest-price award
- Eligibility (from notice): All-ministry unified qualification, 'goods sales', grade A–C, 東甲信越地域 region – verify in the tender documents
- Status: Active
- Technology relevance: Possible
- Business-action likelihood: Medium – Open competitive bidding with detailed qualification requirements and a defined deadline; local presence or partnership likely needed due to service and maintenance requirements.
Official Notice
Official Source
KKJ, Japan's Government Procurement Information Website, which aggregates procurement notices from national and local public-sector organizations.
- Source: KKJ (Government Procurement Information Website)
- Official category: 一般競争入札
- Publication date: September 7, 2026
- Publication: Official notice document (PDF)
Full English Translation
The following English translation was prepared from the original Japanese notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website. The translation below is based on the Japanese source text.
September 7, 2026
The following is subject to open competitive bidding.
National Research and Development Agency
National Cancer Center
Director Manno Hiroyuki
1. Matters subject to competitive bidding
(1) Procurement subject and quantity
[Medical Equipment Investment for FY2026] Complete Medical Equipment Management System
(2) Characteristics of the procurement subject
According to the bidding documents and specifications
(3) Delivery deadline or performance period
By March 31, 2027 from the contract conclusion date
(4) Delivery or performance location
National Cancer Center Central Hospital
(5) Bidding method
The first negotiation right holder will be decided by the lowest price bid method, so:
① The bid submitted by bidders shall include all direct expenses related to the procurement subject, including equipment, materials, machinery, transportation costs, and all other expenses required for the commissioned work, estimating the contract amount.
② When deciding the first negotiation right holder, the bid amount will be considered as the bid amount plus 10% of that amount (fractions less than 1 yen will be rounded down). Bidders must submit a bid form stating the amount equivalent to 100/110 of the estimated contract amount, regardless of whether they are taxable or tax-exempt for consumption tax and local consumption tax. *Except when the consumption tax rate differs from the above.
③ This competition will be conducted on a total price basis.
2. Qualifications required for participants
(1) Those who fall under the provisions of Articles 6 and 7 of the National Cancer Center Contract Handling Rules shall not participate.
(2) Those who fall under the following may be excluded from participation:
① Those who have false statements in qualification application or attached documents
② Those whose management condition or creditworthiness has severely deteriorated
(3) Those who have been rated A, B, or C in "Manufacturing of goods" or "Sales of goods" in the qualification examination result notification (unified qualification for all ministries and agencies) and have competitive qualifications in the Kanto-Koshinetsu region.
(4) Those who can prove a system for rapid after-sales service and maintenance for the purchased goods, except for service provision.
3. Place and period for indicating contract terms
Place for contract terms, distribution of bidding documents, and submission of bids:
National Cancer Center Finance and Accounting Department (Tsukiji Campus) Procurement Section
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
Distribution period of bidding documents:
September 7 to September 30, 2026 (Weekdays 8:30 AM to 5:00 PM)
Bid receipt deadline:
September 30, 2026, 5:00 PM (must arrive by then)
4. Place and date of competition execution
Place: National Cancer Center Management Building 1F Meeting Room A, 5-1-1 Tsukiji, Chuo-ku, Tokyo
Date: October 2, 2026 (Friday) 10:30 AM
5. Other matters
(1) Language and currency used in contract procedures
Japanese and Japanese currency
(2) Invalid bids
Bids submitted by those without competitive qualifications or who fail to fulfill required obligations will be invalid.
(3) Necessity of contract document
Required
(4) Method of contractor decision
Among bidders who submit bids with attached documents/materials in accordance with this announcement and bidding documents, who meet all qualification and specification requirements, and whose bid is within the price limit set by Articles 37 and 38 of the National Cancer Center Contract Handling Rules, the lowest price bidder will be the first negotiation right holder and the negotiation partner.
(5) Others
Details are according to the bidding documents.
[Contact]
National Cancer Center Finance and Accounting Department (Tsukiji Campus) Procurement Section, Procurement First Group, Ishigami
Phone: 03-3547-5201 (ext. 3446)
Inquiries limited to matters related to this announcement.
Show original Japanese notice
入 札 公 告令 和8年9月7日次のとおり一般競争に付す。国立研究開発法人国立がん研究センター理事長 間野 博行1競争入札に付する事項(1)調達件名及び数量【令和8年度医療機器投資】医療機器管理システム一式(2)調達件名の特質等入札説明書及び仕様書による(3)納入期限 又は履行期間契約締結日から令和9年3月31日まで(4)納入場所 又は履行場所国立がん研究センター中央病院(5)入札方法第一交渉権者の決定は、最低価格落札方式をもって行うので、①入札者が提出する入札書は、調達件名にかかる直接経費の他、機材、資材、機械器具、運搬費等、業務委託に要する一切の諸経費を含め、契約金額を見積もるものとする。②第一交渉権者決定にあたっては、入札書に記載された金額に当該金額の10%に相当する額を加算した金額(当該金額に1円未満の端数がある場合は、その端数金額を切り捨てた金額とする。)をもって落札金額とするので、入札者は、消費税及び地方消費税に係る課税事業者であるか免税事業者であるかを問わず、見積もった契約金額の110分の100に相当する金額を記載した入札書を提出しなければならない。※前記の消費税率とならない場合を除く③本競争は総価で行う。2競争に参加する者に必要な資格に関する事項(1)国立研究開発法人国立がん研究センター契約事務取扱細則第6条及び7条に規定される各事項に該当される者は、競争に参加できない。(2)次の事項に該当する者は、競争に参加させないことがある。①資格審査申請書又は添付書類に虚偽の事実を記載した者②経営の状況又は信用度が極度に悪化している者(3)資格審査結果通知書(全省庁統一資格)において、「物品の製造」又は「物品の販売」のうちA、B又はCの等級に格付けされ、関東甲信越地域の競争資格を有する者。(4)購入物品等に係る迅速なアフターサービス・メンテナンス等の体制が整備されていることを証明したものであること。但し、役務の提供等については、この限りではない。3契約条項を示す場所 及び期間契約条項を示す場所 、入札説明書の交付場所 、入札書の提出場所は、次のとおりとする。〒104-0045東京都中央区築地5-1-1国立がん研究センター財務経理部(築地キャンパス)調達課入札説明書等交付期間令和8年9月7日から令和8年9月30日まで(平日:午前8時30分から午後5時まで)入札書受領期限令和8年9月30日 午後5時(必着)4競争執行の場所及び日時場所:東京都中央区築地5-1-1国立がん研究センター管理棟1階 会議室A日時:令和8年10月2日(金) 午前10時30分5 その他の事項(1)契約手続において使用する言語及び通貨日本語及び日本国通貨とする。(2)入札の無効本公告に示した競争参加資格 のない者の提出した入札書、入札者に求められる義務を履行しなかった者の提出した入札書は無効とする。(3)契約書作成の要否要(4)契約者の決定方法本公告及び入札説明書に従い、書類・資料を添付した入札書を提出した入札者であって、本入札公告及び入札説明書の競争参加資格 及び仕様書の要求、要件を全て満たし、当該入札者の入札書が国立がん研究センター契約事務取扱細則第37条、38条の規定に基づいて作成された予定価格の制限の範囲内であり、かつ、最低価格をもって入札を行った者を第一交渉権者とし、契約交渉の相手方とする。(5)その他詳細は入札説明書による。【照会先】国立がん研究センター財務経理部(築地キャンパス)調達課調達第一係石神電話03-3547-5201(内線3446)なお、照会内容は本公告に係る事項のみとする。
Business Signal
Business Relevance
May interest companies providing medical equipment management systems and integrated hospital IT solutions, especially those capable of delivering comprehensive system packages for medical institutions.
Participation fit
Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.
This page is based on the official procurement notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.
JBid is a beta technology-procurement intelligence service by I.J. Do.